HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Riggs, J. E. Articles by Penn, A. S. Search for Related Content PubMed PubMed Citation Articles by Riggs, J. E. Articles by Penn, A. S.

Heterozygous C2-deficiency and myasthenia gravis

Departments of Neurology (Drs. Riggs and Griggs), Medicine (Dr. Rosenfeld), and Surgery (Dr. May), University of Rochester School of Medicine and Dentistry, Rochester, NY, and the Department of Neurology and the H. Houston Merritt Center for Muscular Dystrophy and Related Diseases (Dr. Perm), Columbia-Presbyterian Medical Center, New York, NY.

Complement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family.

Address correspondence and reprint requests to Dr. Riggs, Department of Neurology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642.

Accepted for publication November 30, 1979.

This work was supported in part by grants from the Muscular Dystrophy Association, Inc., the Gannett Foundation, and Center Grant No. NS-11766 from the National Institute of Neurological and Communicative Disorders and Stroke. Dr. Riggs is a recipient of a Muscular Dystrophy Association, Inc. Clinical Fellowship.